![]() Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | RGD:2319357 | 6480464 | 2 more ... | CTD | PMID:27291303 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1557692 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NFATC1 mRNA | CTD | PMID:20819909, PMID:24058054 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1557692 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to NFATC1 gene] | CTD | PMID:20819909 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1557692 | 6480464 | Tetrachlorodibenzodioxin affects the expression of NFATC1 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | affects localization | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the localization of NFATC1 protein | CTD | PMID:19028555 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of NFATC1 protein], Cyclosporine inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of NFATC1 protein] | CTD | PMID:19028555 | 2-aminopurine | multiple interactions | ISO | RGD:1557692 | 6480464 | 2-Aminopurine inhibits the reaction [TNF protein affects the localization of NFATC1 protein], 2-Aminopurine inhibits the reaction [TNF protein promotes the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]] | CTD | PMID:25739386 | 2-tert-butylhydroquinone | multiple interactions | ISO | RGD:1557692 | 6480464 | [TNFSF11 protein co-treated with CSF1 protein co-treated with 2-tert-butylhydroquinone] results in decreased expression of NFATC1 protein | CTD | PMID:23112101 | 3'-O-(4-Benzoyl)benzoyl ATP | affects localization | ISO | RGD:1557692 | 6480464 | 3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate affects the localization of NFATC1 protein | CTD | PMID:26522449 | 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:1557692 | 6480464 | 4, 4'-diaminodiphenylmethane results in decreased expression of NFATC1 mRNA | CTD | PMID:18648102 | 4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide | multiple interactions | ISO | RGD:1557692 | 6480464 | Cisapride inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mRNA] | CTD | PMID:31150804 | 4-hydroxynon-2-enal | decreases expression | EXP | | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of NFATC1 mRNA | CTD | PMID:12419474 | 4-hydroxyphenyl retinamide | decreases expression | ISO | RGD:1557692 | 6480464 | Fenretinide results in decreased expression of NFATC1 mRNA | CTD | PMID:16467112 | 5-aza-2'-deoxycytidine | decreases expression | EXP | | 6480464 | Decitabine results in decreased expression of NFATC1 mRNA | CTD | PMID:17785578 | 5-azacytidine | increases expression | EXP | | 6480464 | Azacitidine results in increased expression of NFATC1 mRNA | CTD | PMID:20823114 | 8-bromo-3',5'-cyclic GMP | affects localization | ISO | RGD:1557692 | 6480464 | 8-bromocyclic GMP affects the localization of NFATC1 protein | CTD | PMID:16533816 | aflatoxin B1 | affects methylation | EXP | | 6480464 | Aflatoxin B1 affects the methylation of NFATC1 intron | CTD | PMID:30157460 | aflatoxin B2 | increases methylation | EXP | | 6480464 | aflatoxin B2 results in increased methylation of NFATC1 intron | CTD | PMID:30157460 | all-trans-retinoic acid | multiple interactions | ISO | RGD:1557692 | 6480464 | Ro 41-5253 inhibits the reaction [Tretinoin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]], Tretinoin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein] | CTD | PMID:17291456 | alpha-naphthoflavone | multiple interactions | EXP | | 6480464 | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of NFATC1 protein] | CTD | PMID:19028555 | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of NFATC1 gene | CTD | PMID:25304211 | arsane | decreases methylation | EXP | | 6480464 | Arsenic results in decreased methylation of NFATC1 gene | CTD | PMID:27838757 | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of NFATC1 gene | CTD | PMID:25304211 | arsenic atom | decreases methylation | EXP | | 6480464 | Arsenic results in decreased methylation of NFATC1 gene | CTD | PMID:27838757 | ATP | affects localization | ISO | RGD:2319357 | 6480464 | Adenosine Triphosphate affects the localization of NFATC1 protein | CTD | PMID:21464294 | ATP | multiple interactions | ISO | RGD:1557692 | 6480464 | azetidine analog inhibits the reaction [Adenosine Triphosphate affects the localization of NFATC1 protein] | CTD | PMID:26522449 | ATP | affects localization | ISO | RGD:1557692 | 6480464 | Adenosine Triphosphate affects the localization of NFATC1 protein | CTD | PMID:26522449 | atrazine | affects methylation | ISO | RGD:2319357 | 6480464 | Atrazine affects the methylation of NFATC1 gene | CTD | PMID:28931070 | azetidine | multiple interactions | ISO | RGD:1557692 | 6480464 | azetidine analog inhibits the reaction [Adenosine Triphosphate affects the localization of NFATC1 protein] | CTD | PMID:26522449 | benzamide | multiple interactions | ISO | RGD:1557692 | 6480464 | benzamide analog inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of and affects the localization of NFATC1 protein], benzamide analog inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of NFATC1 mRNA] | CTD | PMID:29935282 | benzene | increases expression | EXP | | 6480464 | Benzene results in increased expression of NFATC1 mRNA | CTD | PMID:19162166 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of NFATC1 mRNA | CTD | PMID:20064835 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of NFATC1 intron | CTD | PMID:30157460 | benzo[a]pyrene | multiple interactions | ISO | RGD:1557692 | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NFATC1 mRNA | CTD | PMID:27858113 | benzo[a]pyrene | increases expression | ISO | RGD:1557692 | 6480464 | Benzo(a)pyrene results in increased expression of NFATC1 mRNA | CTD | PMID:22228805 | benzo[b]fluoranthene | multiple interactions | ISO | RGD:1557692 | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NFATC1 mRNA | CTD | PMID:27858113 | benzo[e]pyrene | increases methylation | EXP | | 6480464 | benzo(e)pyrene results in increased methylation of NFATC1 intron | CTD | PMID:30157460 | bisphenol A | decreases expression | ISO | RGD:1557692 | 6480464 | bisphenol A results in decreased expression of NFATC1 mRNA | CTD | PMID:23900028, PMID:26063408 | bisphenol A | increases methylation | ISO | RGD:2319357 | 6480464 | bisphenol A results in increased methylation of NFATC1 gene | CTD | PMID:28505145 | bisphenol A | affects methylation | ISO | RGD:1557692 | 6480464 | bisphenol A affects the methylation of NFATC1 promoter | CTD | PMID:27334623 | buta-1,3-diene | decreases expression | ISO | RGD:1557692 | 6480464 | 1, 3-butadiene results in decreased expression of NFATC1 mRNA | CTD | PMID:29038090 | Calcimycin | multiple interactions | EXP | | 6480464 | [Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of NFATC1 protein more ... | CTD | PMID:21603612, PMID:24244623 | carbon nanotube | decreases expression | ISO | RGD:1557692 | 6480464 | Nanotubes, Carbon analog results in decreased expression of NFATC1 mRNA, Nanotubes, Carbon results in decreased expression of NFATC1 mRNA | CTD | PMID:25554681 | chlorpromazine | multiple interactions | ISO | RGD:1557692 | 6480464 | Chlorpromazine inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mRNA] | CTD | PMID:21869564 | choline | multiple interactions | ISO | RGD:1557692 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NFATC1 gene | CTD | PMID:20938992 | chromium(3+) trichloride | multiple interactions | ISO | RGD:1557692 | 6480464 | [cobaltous chloride co-treated with chromic chloride] results in increased expression of NFATC1 mRNA | CTD | PMID:25966675 | chrysene | multiple interactions | ISO | RGD:1557692 | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NFATC1 mRNA | CTD | PMID:27858113 | cisapride | multiple interactions | ISO | RGD:1557692 | 6480464 | Cisapride inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mRNA] | CTD | PMID:31150804 | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of NFATC1 mRNA | CTD | PMID:27392435 | cobalt dichloride | multiple interactions | ISO | RGD:1557692 | 6480464 | [cobaltous chloride co-treated with chromic chloride] results in increased expression of NFATC1 mRNA | CTD | PMID:25966675 | cobalt dichloride | increases expression | ISO | RGD:1557692 | 6480464 | cobaltous chloride results in increased expression of NFATC1 mRNA | CTD | PMID:25966675 | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of NFATC1 mRNA | CTD | PMID:19549813 | CU-O LINKAGE | increases expression | EXP | | 6480464 | cupric oxide results in increased expression of NFATC1 mRNA | CTD | PMID:22077320 | cyclosporin A | multiple interactions | ISO | RGD:2319357 | 6480464 | Cyclosporine inhibits the reaction [Isoproterenol affects the localization of NFATC1 protein], Cyclosporine inhibits the reaction [Phenylephrine results in increased localization of and results in increased activity of NFATC1 protein] | CTD | PMID:11435416, PMID:19349967 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of NFATC1 protein | CTD | PMID:24244623 | cyclosporin A | multiple interactions | EXP | | 6480464 | [Cyclosporine co-treated with NGF protein] affects the localization of NFATC1 protein more ... | CTD | PMID:19028555, PMID:24244623 | decabromodiphenyl ether | increases expression | ISO | RGD:2319357 | 6480464 | decabromobiphenyl ether results in increased expression of NFATC1 mRNA | CTD | PMID:23640034 | deoxynivalenol | affects localization | EXP | | 6480464 | deoxynivalenol affects the localization of NFATC1 protein | CTD | PMID:22846391 | deoxynivalenol | affects localization | ISO | RGD:1557692 | 6480464 | deoxynivalenol affects the localization of NFATC1 protein | CTD | PMID:21074547 | dioxygen | affects localization | EXP | | 6480464 | Oxygen deficiency affects the localization of NFATC1 protein | CTD | PMID:19028555 | dioxygen | multiple interactions | EXP | | 6480464 | Cyclosporine inhibits the reaction [Oxygen deficiency affects the localization of NFATC1 protein] | CTD | PMID:19028555 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFATC1 mRNA | CTD | PMID:27188386 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of NFATC1 mRNA | CTD | PMID:29803840 | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of NFATC1 mRNA | CTD | PMID:26272509, PMID:27188386 | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFATC1 mRNA | CTD | PMID:27188386 | ethanol | increases expression | ISO | RGD:1557692 | 6480464 | Ethanol results in increased expression of NFATC1 mRNA | CTD | PMID:30319688 | folic acid | multiple interactions | ISO | RGD:1557692 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NFATC1 gene | CTD | PMID:20938992 | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of NFATC1 mRNA | CTD | PMID:17938736 | genistein | multiple interactions | ISO | RGD:1557692 | 6480464 | Genistein promotes the reaction [[CSF1 protein co-treated with TNFSF11 protein co-treated with Zinc Sulfate] results in decreased expression of NFATC1 mRNA] | CTD | PMID:17295206 | ginsenoside Rb1 | multiple interactions | ISO | RGD:1557692 | 6480464 | ginsenoside Rb1 inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mRNA] | CTD | PMID:22386813 | harmine | affects localization | EXP | | 6480464 | Harmine affects the localization of NFATC1 protein | CTD | PMID:25751815 | hydrogen peroxide | multiple interactions | ISO | RGD:1557692 | 6480464 | Hydrogen Peroxide inhibits the reaction [Ionomycin results in decreased phosphorylation of NFATC1 protein] | CTD | PMID:12203019 | hydrogen peroxide | decreases activity | ISO | RGD:1557692 | 6480464 | Hydrogen Peroxide results in decreased activity of NFATC1 protein | CTD | PMID:12203019 | hypoxanthine | decreases activity | ISO | RGD:1557692 | 6480464 | Hypoxanthine results in decreased activity of NFATC1 protein | CTD | PMID:12203019 | ionomycin | multiple interactions | ISO | RGD:1557692 | 6480464 | Hydrogen Peroxide inhibits the reaction [Ionomycin results in decreased phosphorylation of NFATC1 protein] | CTD | PMID:12203019 | ionomycin | decreases phosphorylation | ISO | RGD:1557692 | 6480464 | Ionomycin results in decreased phosphorylation of NFATC1 protein | CTD | PMID:12203019 | isoprenaline | affects localization | ISO | RGD:2319357 | 6480464 | Isoproterenol affects the localization of NFATC1 protein | CTD | PMID:11435416 | isoprenaline | multiple interactions | ISO | RGD:2319357 | 6480464 | Cyclosporine inhibits the reaction [Isoproterenol affects the localization of NFATC1 protein], Isoproterenol promotes the reaction [NFATC1 protein binds to GATA4 protein] | CTD | PMID:11435416 | L-methionine | multiple interactions | ISO | RGD:1557692 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NFATC1 gene | CTD | PMID:20938992 | lead(0) | increases expression | ISO | RGD:1557692 | 6480464 | Lead results in increased expression of NFATC1 mRNA | CTD | PMID:26518054 | lead(2+) | increases expression | ISO | RGD:1557692 | 6480464 | Lead results in increased expression of NFATC1 mRNA | CTD | PMID:26518054 | lipopolysaccharide | decreases expression | ISO | RGD:1557692 | 6480464 | Lipopolysaccharides results in decreased expression of NFATC1 mRNA | CTD | PMID:22185406 | lipopolysaccharide | multiple interactions | EXP | | 6480464 | EIF2AK2 protein affects the reaction [Lipopolysaccharides promotes the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]] more ... | CTD | PMID:27718290 | lipopolysaccharide | multiple interactions | ISO | RGD:1557692 | 6480464 | Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of NFATC1 mRNA], Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of NFATC1 protein] | CTD | PMID:30048646 | lipopolysaccharide | increases expression | ISO | RGD:1557692 | 6480464 | Lipopolysaccharides results in increased expression of NFATC1 mRNA, Lipopolysaccharides results in increased expression of NFATC1 protein | CTD | PMID:30048646 | methapyrilene | increases methylation | EXP | | 6480464 | Methapyrilene results in increased methylation of NFATC1 intron | CTD | PMID:30157460 | methylglyoxal | multiple interactions | ISO | RGD:1557692 | 6480464 | [TNFSF11 protein co-treated with Pyruvaldehyde] affects the expression of NFATC1 mRNA | CTD | PMID:30217477 | N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1557692 | 6480464 | Acetylcysteine affects the reaction [NFE2L2 protein affects the reaction [sodium arsenite affects the expression of NFATC1 protein]], Acetylcysteine affects the reaction [sodium arsenite affects the expression of NFATC1 protein] | CTD | PMID:30742845 | Niclosamide | multiple interactions | ISO | RGD:1557692 | 6480464 | Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of and affects the localization of NFATC1 protein], Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of NFATC1 mRNA] | CTD | PMID:28824321 | Niclosamide | multiple interactions | EXP | | 6480464 | Niclosamide inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mRNA], Niclosamide inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein] | CTD | PMID:26792726 | ochratoxin A | increases expression | EXP | | 6480464 | ochratoxin A results in increased expression of NFATC1 mRNA | CTD | PMID:29098329 | ochratoxin A | multiple interactions | EXP | | 6480464 | [ochratoxin A results in increased acetylation of NFATC1 promoter] which results in increased expression of NFATC1 mRNA | CTD | PMID:29098329 | ochratoxin A | increases acetylation | EXP | | 6480464 | ochratoxin A results in increased acetylation of NFATC1 promoter | CTD | PMID:29098329 | oxaliplatin | multiple interactions | ISO | RGD:2319357 | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of NFATC1 mRNA | CTD | PMID:25729387 | p-menthan-3-ol | increases expression | EXP | | 6480464 | Menthol results in increased expression of NFATC1 mRNA | CTD | PMID:26760959 | paracetamol | affects expression | ISO | RGD:1557692 | 6480464 | Acetaminophen affects the expression of NFATC1 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | ISO | RGD:1557692 | 6480464 | Acetaminophen results in increased expression of NFATC1 mRNA | CTD | PMID:17585979 | perfluorooctane-1-sulfonic acid | affects expression | EXP | | 6480464 | perfluorooctane sulfonic acid affects the expression of NFATC1 mRNA | CTD | PMID:30738844 | phenobarbital | affects expression | ISO | RGD:1557692 | 6480464 | Phenobarbital affects the expression of NFATC1 mRNA | CTD | PMID:23091169 | phenylephrine | multiple interactions | ISO | RGD:2319357 | 6480464 | Cyclosporine inhibits the reaction [Phenylephrine results in increased localization of and results in increased activity of NFATC1 protein] more ... | CTD | PMID:12403671, PMID:19349967 | phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | [Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of NFATC1 protein more ... | CTD | PMID:21603612, PMID:24244623 | platycodin D | multiple interactions | ISO | RGD:2319357 | 6480464 | platycodin D inhibits the reaction [TNFSF11 protein results in increased expression of and results in increased activity of NFATC1 protein] | CTD | PMID:27739107 | platycodin D | multiple interactions | ISO | RGD:1557692 | 6480464 | platycodin D affects the expression of and affects the localization of NFATC1 protein | CTD | PMID:26184636 | quercetin | decreases expression | ISO | RGD:1557692 | 6480464 | Quercetin results in decreased expression of NFATC1 mRNA | CTD | PMID:22185406 | quercetin | multiple interactions | ISO | RGD:1557692 | 6480464 | Quercetin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein] | CTD | PMID:19495926 | raloxifene | multiple interactions | EXP | | 6480464 | [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of NFATC1 mRNA | CTD | PMID:19059307 | resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of NFATC1 mRNA] | CTD | PMID:16267019 | Ro 41-5253 | multiple interactions | ISO | RGD:1557692 | 6480464 | Ro 41-5253 inhibits the reaction [Tretinoin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]], Ro 41-5253 inhibits the reaction [tributyltin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]] | CTD | PMID:17291456 | rotenone | multiple interactions | EXP | | 6480464 | Rotenone inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mRNA], Rotenone inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein] | CTD | PMID:19900598 | SB 203580 | multiple interactions | ISO | RGD:1557692 | 6480464 | SB 203580 affects the reaction [NFE2L2 protein affects the reaction [sodium arsenite affects the expression of NFATC1 protein]], SB 203580 affects the reaction [sodium arsenite affects the expression of NFATC1 protein] | CTD | PMID:30742845 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFATC1 mRNA | CTD | PMID:27188386 | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide analog results in decreased expression of NFATC1 mRNA | CTD | PMID:25895662 | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide analog results in increased expression of NFATC1 mRNA | CTD | PMID:23806026 | silver atom | increases expression | ISO | RGD:1557692 | 6480464 | Silver results in increased expression of NFATC1 mRNA | CTD | PMID:27131904 | silver(0) | increases expression | ISO | RGD:1557692 | 6480464 | Silver results in increased expression of NFATC1 mRNA | CTD | PMID:27131904 | sodium arsenite | multiple interactions | ISO | RGD:1557692 | 6480464 | Acetylcysteine affects the reaction [NFE2L2 protein affects the reaction [sodium arsenite affects the expression of NFATC1 protein]] more ... | CTD | PMID:30742845 | sodium arsenite | multiple interactions | EXP | | 6480464 | sodium arsenite affects the expression of and results in decreased phosphorylation of NFATC1 protein, U 0126 affects the reaction [sodium arsenite affects the expression of NFATC1 protein] | CTD | PMID:29528074 | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of NFATC1 mRNA | CTD | PMID:29528074 | sodium arsenite | affects localization | EXP | | 6480464 | sodium arsenite affects the localization of NFATC1 protein | CTD | PMID:29528074 | sodium arsenite | affects expression | ISO | RGD:1557692 | 6480464 | sodium arsenite affects the expression of NFATC1 protein | CTD | PMID:30742845 | tamoxifen | multiple interactions | EXP | | 6480464 | [Tamoxifen co-treated with ESR2 protein] results in decreased expression of NFATC1 mRNA | CTD | PMID:19059307 | tamoxifen | increases expression | ISO | RGD:1557692 | 6480464 | Tamoxifen results in increased expression of NFATC1 mRNA | CTD | PMID:19031437 | tert-butyl hydroperoxide | decreases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in decreased expression of NFATC1 mRNA | CTD | PMID:12419474 | tetraphene | multiple interactions | ISO | RGD:1557692 | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NFATC1 mRNA | CTD | PMID:27858113 | thapsigargin | multiple interactions | EXP | | 6480464 | Thapsigargin promotes the reaction [PPP3CA protein results in decreased phosphorylation of NFATC1 protein] | CTD | PMID:10898953 | thymol | multiple interactions | ISO | RGD:1557692 | 6480464 | Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of NFATC1 mRNA] more ... | CTD | PMID:30048646 | thymol sulfate(1-) | multiple interactions | ISO | RGD:1557692 | 6480464 | Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of NFATC1 mRNA] more ... | CTD | PMID:30048646 | tofacitinib | multiple interactions | EXP | | 6480464 | tofacitinib promotes the reaction [TNF protein affects the localization of NFATC1 protein] | CTD | PMID:22941906 | topotecan | decreases expression | ISO | RGD:2319357 | 6480464 | Topotecan results in decreased expression of NFATC1 mRNA | CTD | PMID:25729387 | topotecan | multiple interactions | ISO | RGD:2319357 | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of NFATC1 mRNA | CTD | PMID:25729387 | tributylstannane | multiple interactions | ISO | RGD:1557692 | 6480464 | Ro 41-5253 inhibits the reaction [tributyltin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]], tributyltin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein] | CTD | PMID:17291456 | Tributyltin oxide | affects localization | EXP | | 6480464 | bis(tri-n-butyltin)oxide affects the localization of NFATC1 protein | CTD | PMID:21601586 | Tributyltin oxide | affects localization | ISO | RGD:1557692 | 6480464 | bis(tri-n-butyltin)oxide affects the localization of NFATC1 protein | CTD | PMID:22434021 | trimellitic anhydride | increases expression | ISO | RGD:1557692 | 6480464 | trimellitic anhydride results in increased expression of NFATC1 mRNA | CTD | PMID:19042947 | triphenylstannane | multiple interactions | ISO | RGD:1557692 | 6480464 | triphenyltin inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein] | CTD | PMID:17291456 | troglitazone | decreases expression | ISO | RGD:1557692 | 6480464 | troglitazone results in decreased expression of NFATC1 mRNA | CTD | PMID:28973697 | tungsten | decreases expression | ISO | RGD:1557692 | 6480464 | Tungsten results in decreased expression of NFATC1 mRNA | CTD | PMID:30912803 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of NFATC1 mRNA | CTD | PMID:25979313 | valproic acid | affects methylation | EXP | | 6480464 | Valproic Acid affects the methylation of NFATC1 gene | CTD | PMID:29501571 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of NFATC1 mRNA | CTD | PMID:28001369 | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of NFATC1 gene | CTD | PMID:28853863 more ... | xanthohumol | multiple interactions | ISO | RGD:1557692 | 6480464 | xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mRNA] | CTD | PMID:23994090 | zinc atom | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of NFATC1 mRNA | CTD | PMID:18593933 | zinc sulfate | multiple interactions | ISO | RGD:1557692 | 6480464 | [Cryptoxanthins co-treated with Zinc Sulfate] results in decreased expression of NFATC1 mRNA more ... | CTD | PMID:17295206, PMID:18636177 | zinc(0) | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of NFATC1 mRNA | CTD | PMID:18593933 | |

Biological Process
Cellular Component
Molecular Function
